iBio, Inc. IBIO
NASDAQ IBIO
$0.84 +0.02 (+2.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

iBio (IBIO) Gross Margin (2020 - 2022)

Updated

iBio (IBIO) reported Gross Margin of 115.02% for FY2022 (year ended Jun 30, 2022), up 76.68 percentage points from 38.34% in FY2021.

Analysis

iBio (IBIO) Gross Margin (2020 - 2022) Analysis & Trends

  • According to Business Quant data, Gross Margin came in at 38.34% in FY2021 (-18.74 pp) and 57.08% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 68.19%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 74.74%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 73.54%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 78.02%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 83.60%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 72.04%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 79.76%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 72.78%
10 iBio 87.41 Mn -177.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 105.28%
Sep 30, 2021 203.57%
Jun 30, 2021 61.91%
Mar 31, 2021 35.56%
Dec 31, 2020 70.07%
Sep 30, 2020 73.90%
Jun 30, 2020 73.30%
Mar 31, 2020 10.42%
API Access

iBio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEY